nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—ESR1—ovarian cancer	0.348	0.702	CbGaD
Clomifene—ABCB1—ovarian cancer	0.148	0.298	CbGaD
Clomifene—CYP19A1—Paclitaxel—ovarian cancer	0.0709	0.341	CbGbCtD
Clomifene—ABCB1—Topotecan—ovarian cancer	0.0303	0.146	CbGbCtD
Clomifene—ABCB1—Vinorelbine—ovarian cancer	0.0213	0.103	CbGbCtD
Clomifene—CYP3A4—Topotecan—ovarian cancer	0.0181	0.0874	CbGbCtD
Clomifene—CYP19A1—follicular fluid—ovarian cancer	0.0157	0.146	CbGeAlD
Clomifene—ABCB1—Paclitaxel—ovarian cancer	0.015	0.0722	CbGbCtD
Clomifene—CYP11A1—corpus luteum—ovarian cancer	0.0139	0.129	CbGeAlD
Clomifene—CYP3A4—Vinorelbine—ovarian cancer	0.0128	0.0616	CbGbCtD
Clomifene—CYP11A1—ovarian follicle—ovarian cancer	0.0109	0.101	CbGeAlD
Clomifene—ABCB1—Docetaxel—ovarian cancer	0.0108	0.0522	CbGbCtD
Clomifene—CYP19A1—corpus luteum—ovarian cancer	0.00905	0.084	CbGeAlD
Clomifene—CYP3A4—Paclitaxel—ovarian cancer	0.00898	0.0433	CbGbCtD
Clomifene—ABCB1—Doxorubicin—ovarian cancer	0.00808	0.0389	CbGbCtD
Clomifene—CYP19A1—ovarian follicle—ovarian cancer	0.00707	0.0657	CbGeAlD
Clomifene—CYP3A4—Docetaxel—ovarian cancer	0.00649	0.0313	CbGbCtD
Clomifene—ESR1—ovarian follicle—ovarian cancer	0.00615	0.0571	CbGeAlD
Clomifene—CYP3A4—Doxorubicin—ovarian cancer	0.00484	0.0233	CbGbCtD
Clomifene—EBP—uterine cervix—ovarian cancer	0.00282	0.0262	CbGeAlD
Clomifene—ESR1—oviduct—ovarian cancer	0.0027	0.0251	CbGeAlD
Clomifene—EBP—uterus—ovarian cancer	0.00235	0.0218	CbGeAlD
Clomifene—EBP—female reproductive system—ovarian cancer	0.00211	0.0196	CbGeAlD
Clomifene—CYP11A1—decidua—ovarian cancer	0.00113	0.0105	CbGeAlD
Clomifene—CYP11A1—gonad—ovarian cancer	0.000999	0.00928	CbGeAlD
Clomifene—SIGMAR1—myometrium—ovarian cancer	0.000978	0.00908	CbGeAlD
Clomifene—CYP11A1—female reproductive system—ovarian cancer	0.000892	0.00829	CbGeAlD
Clomifene—ESR1—myometrium—ovarian cancer	0.000864	0.00803	CbGeAlD
Clomifene—Ospemifene—ESR1—ovarian cancer	0.000845	0.322	CrCbGaD
Clomifene—ESR1—embryo—ovarian cancer	0.000831	0.00772	CbGeAlD
Clomifene—CYP11A1—female gonad—ovarian cancer	0.000812	0.00754	CbGeAlD
Clomifene—KCNH2—myometrium—ovarian cancer	0.000778	0.00723	CbGeAlD
Clomifene—SIGMAR1—uterine cervix—ovarian cancer	0.000761	0.00706	CbGeAlD
Clomifene—SIGMAR1—decidua—ovarian cancer	0.000725	0.00673	CbGeAlD
Clomifene—CYP11A1—testis—ovarian cancer	0.00072	0.00669	CbGeAlD
Clomifene—CYP19A1—endometrium—ovarian cancer	0.0007	0.0065	CbGeAlD
Clomifene—Toremifene—ESR1—ovarian cancer	0.000689	0.262	CrCbGaD
Clomifene—SIGMAR1—endometrium—ovarian cancer	0.000688	0.00639	CbGeAlD
Clomifene—ESR1—epithelium—ovarian cancer	0.000678	0.0063	CbGeAlD
Clomifene—ESR1—uterine cervix—ovarian cancer	0.000673	0.00625	CbGeAlD
Clomifene—CYP2A6—vagina—ovarian cancer	0.000669	0.00621	CbGeAlD
Clomifene—CYP19A1—gonad—ovarian cancer	0.000649	0.00603	CbGeAlD
Clomifene—CYP19A1—uterus—ovarian cancer	0.000645	0.00599	CbGeAlD
Clomifene—ESR1—decidua—ovarian cancer	0.000641	0.00595	CbGeAlD
Clomifene—SIGMAR1—uterus—ovarian cancer	0.000634	0.00589	CbGeAlD
Clomifene—ESR1—endometrium—ovarian cancer	0.000608	0.00565	CbGeAlD
Clomifene—KCNH2—uterine cervix—ovarian cancer	0.000606	0.00562	CbGeAlD
Clomifene—CYP19A1—female reproductive system—ovarian cancer	0.00058	0.00538	CbGeAlD
Clomifene—ESR1—gonad—ovarian cancer	0.000564	0.00524	CbGeAlD
Clomifene—ESR1—uterus—ovarian cancer	0.000561	0.00521	CbGeAlD
Clomifene—KCNH2—endometrium—ovarian cancer	0.000548	0.00509	CbGeAlD
Clomifene—SIGMAR1—bone marrow—ovarian cancer	0.000538	0.005	CbGeAlD
Clomifene—CYP19A1—female gonad—ovarian cancer	0.000528	0.0049	CbGeAlD
Clomifene—CYP11A1—lymph node—ovarian cancer	0.000522	0.00485	CbGeAlD
Clomifene—SIGMAR1—female gonad—ovarian cancer	0.000519	0.00482	CbGeAlD
Clomifene—CYP1A1—epithelium—ovarian cancer	0.000516	0.00479	CbGeAlD
Clomifene—SIGMAR1—vagina—ovarian cancer	0.000516	0.00479	CbGeAlD
Clomifene—CYP1A1—uterine cervix—ovarian cancer	0.000511	0.00475	CbGeAlD
Clomifene—KCNH2—uterus—ovarian cancer	0.000505	0.00469	CbGeAlD
Clomifene—ESR1—female reproductive system—ovarian cancer	0.000504	0.00468	CbGeAlD
Clomifene—CYP19A1—testis—ovarian cancer	0.000468	0.00435	CbGeAlD
Clomifene—SIGMAR1—testis—ovarian cancer	0.00046	0.00427	CbGeAlD
Clomifene—ESR1—female gonad—ovarian cancer	0.000459	0.00426	CbGeAlD
Clomifene—ESR1—vagina—ovarian cancer	0.000456	0.00423	CbGeAlD
Clomifene—KCNH2—female reproductive system—ovarian cancer	0.000454	0.00421	CbGeAlD
Clomifene—KCNH2—bone marrow—ovarian cancer	0.000428	0.00398	CbGeAlD
Clomifene—CYP1A1—uterus—ovarian cancer	0.000426	0.00396	CbGeAlD
Clomifene—KCNH2—female gonad—ovarian cancer	0.000413	0.00383	CbGeAlD
Clomifene—KCNH2—vagina—ovarian cancer	0.00041	0.00381	CbGeAlD
Clomifene—Tamoxifen—CYP1B1—ovarian cancer	0.000407	0.155	CrCbGaD
Clomifene—ESR1—testis—ovarian cancer	0.000407	0.00378	CbGeAlD
Clomifene—CYP1A1—female reproductive system—ovarian cancer	0.000383	0.00356	CbGeAlD
Clomifene—KCNH2—testis—ovarian cancer	0.000366	0.0034	CbGeAlD
Clomifene—CYP2E1—female reproductive system—ovarian cancer	0.000349	0.00324	CbGeAlD
Clomifene—CYP1A1—female gonad—ovarian cancer	0.000349	0.00324	CbGeAlD
Clomifene—CYP1A1—vagina—ovarian cancer	0.000347	0.00322	CbGeAlD
Clomifene—ABCB1—myometrium—ovarian cancer	0.000341	0.00317	CbGeAlD
Clomifene—CYP19A1—lymph node—ovarian cancer	0.000339	0.00315	CbGeAlD
Clomifene—SIGMAR1—lymph node—ovarian cancer	0.000333	0.0031	CbGeAlD
Clomifene—ABCB1—embryo—ovarian cancer	0.000328	0.00305	CbGeAlD
Clomifene—ESR1—lymph node—ovarian cancer	0.000295	0.00274	CbGeAlD
Clomifene—Toremifene—ABCB1—ovarian cancer	0.000293	0.111	CrCbGaD
Clomifene—CYP2E1—testis—ovarian cancer	0.000282	0.00262	CbGeAlD
Clomifene—CYP3A4—female reproductive system—ovarian cancer	0.000281	0.00261	CbGeAlD
Clomifene—Tamoxifen—ESR1—ovarian cancer	0.000275	0.105	CrCbGaD
Clomifene—ABCB1—epithelium—ovarian cancer	0.000268	0.00249	CbGeAlD
Clomifene—ABCB1—uterine cervix—ovarian cancer	0.000266	0.00247	CbGeAlD
Clomifene—KCNH2—lymph node—ovarian cancer	0.000265	0.00246	CbGeAlD
Clomifene—ABCB1—decidua—ovarian cancer	0.000253	0.00235	CbGeAlD
Clomifene—ABCB1—endometrium—ovarian cancer	0.00024	0.00223	CbGeAlD
Clomifene—CYP1A1—lymph node—ovarian cancer	0.000224	0.00208	CbGeAlD
Clomifene—ABCB1—gonad—ovarian cancer	0.000223	0.00207	CbGeAlD
Clomifene—ABCB1—uterus—ovarian cancer	0.000221	0.00206	CbGeAlD
Clomifene—ABCB1—female reproductive system—ovarian cancer	0.000199	0.00185	CbGeAlD
Clomifene—ABCB1—bone marrow—ovarian cancer	0.000188	0.00174	CbGeAlD
Clomifene—ABCB1—female gonad—ovarian cancer	0.000181	0.00168	CbGeAlD
Clomifene—ABCB1—vagina—ovarian cancer	0.00018	0.00167	CbGeAlD
Clomifene—Weight increased—Docetaxel—ovarian cancer	0.000177	0.00134	CcSEcCtD
Clomifene—Visual impairment—Paclitaxel—ovarian cancer	0.000177	0.00134	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000176	0.00134	CcSEcCtD
Clomifene—Urticaria—Melphalan—ovarian cancer	0.000176	0.00133	CcSEcCtD
Clomifene—Phlebitis—Epirubicin—ovarian cancer	0.000176	0.00133	CcSEcCtD
Clomifene—Thrombophlebitis—Epirubicin—ovarian cancer	0.000175	0.00133	CcSEcCtD
Clomifene—Neoplasm—Doxorubicin—ovarian cancer	0.000175	0.00132	CcSEcCtD
Clomifene—Diarrhoea—Chlorambucil—ovarian cancer	0.000174	0.00132	CcSEcCtD
Clomifene—Paraesthesia—Vinorelbine—ovarian cancer	0.000174	0.00132	CcSEcCtD
Clomifene—Erythema multiforme—Paclitaxel—ovarian cancer	0.000173	0.00131	CcSEcCtD
Clomifene—Dyspnoea—Vinorelbine—ovarian cancer	0.000173	0.00131	CcSEcCtD
Clomifene—Tinnitus—Paclitaxel—ovarian cancer	0.000171	0.00129	CcSEcCtD
Clomifene—Renal failure—Docetaxel—ovarian cancer	0.00017	0.00129	CcSEcCtD
Clomifene—Flushing—Paclitaxel—ovarian cancer	0.00017	0.00129	CcSEcCtD
Clomifene—Jaundice—Docetaxel—ovarian cancer	0.000169	0.00128	CcSEcCtD
Clomifene—Eye pain—Epirubicin—ovarian cancer	0.000168	0.00127	CcSEcCtD
Clomifene—Mental disability—Doxorubicin—ovarian cancer	0.000168	0.00127	CcSEcCtD
Clomifene—Fatigue—Vinorelbine—ovarian cancer	0.000167	0.00126	CcSEcCtD
Clomifene—Hypersensitivity—Topotecan—ovarian cancer	0.000167	0.00126	CcSEcCtD
Clomifene—Pain—Vinorelbine—ovarian cancer	0.000166	0.00125	CcSEcCtD
Clomifene—Constipation—Vinorelbine—ovarian cancer	0.000166	0.00125	CcSEcCtD
Clomifene—Arrhythmia—Paclitaxel—ovarian cancer	0.000164	0.00124	CcSEcCtD
Clomifene—Hypersensitivity—Melphalan—ovarian cancer	0.000163	0.00124	CcSEcCtD
Clomifene—Phlebitis—Doxorubicin—ovarian cancer	0.000163	0.00123	CcSEcCtD
Clomifene—Asthenia—Topotecan—ovarian cancer	0.000162	0.00123	CcSEcCtD
Clomifene—Alopecia—Paclitaxel—ovarian cancer	0.000162	0.00123	CcSEcCtD
Clomifene—Hot flush—Epirubicin—ovarian cancer	0.000162	0.00123	CcSEcCtD
Clomifene—Thrombophlebitis—Doxorubicin—ovarian cancer	0.000162	0.00123	CcSEcCtD
Clomifene—Vomiting—Chlorambucil—ovarian cancer	0.000162	0.00122	CcSEcCtD
Clomifene—Increased appetite—Epirubicin—ovarian cancer	0.000161	0.00122	CcSEcCtD
Clomifene—ABCB1—testis—ovarian cancer	0.000161	0.00149	CbGeAlD
Clomifene—Menopausal symptoms—Epirubicin—ovarian cancer	0.000161	0.00122	CcSEcCtD
Clomifene—Pruritus—Topotecan—ovarian cancer	0.00016	0.00121	CcSEcCtD
Clomifene—Erythema—Paclitaxel—ovarian cancer	0.00016	0.00121	CcSEcCtD
Clomifene—Asthenia—Melphalan—ovarian cancer	0.000159	0.0012	CcSEcCtD
Clomifene—Flatulence—Paclitaxel—ovarian cancer	0.000157	0.00119	CcSEcCtD
Clomifene—Pruritus—Melphalan—ovarian cancer	0.000157	0.00119	CcSEcCtD
Clomifene—Tension—Paclitaxel—ovarian cancer	0.000157	0.00119	CcSEcCtD
Clomifene—Hepatitis—Docetaxel—ovarian cancer	0.000155	0.00118	CcSEcCtD
Clomifene—Eye pain—Doxorubicin—ovarian cancer	0.000155	0.00118	CcSEcCtD
Clomifene—Nervousness—Paclitaxel—ovarian cancer	0.000155	0.00117	CcSEcCtD
Clomifene—Diarrhoea—Topotecan—ovarian cancer	0.000155	0.00117	CcSEcCtD
Clomifene—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000155	0.00117	CcSEcCtD
Clomifene—Back pain—Paclitaxel—ovarian cancer	0.000154	0.00117	CcSEcCtD
Clomifene—Urticaria—Vinorelbine—ovarian cancer	0.000154	0.00117	CcSEcCtD
Clomifene—Body temperature increased—Vinorelbine—ovarian cancer	0.000153	0.00116	CcSEcCtD
Clomifene—Diarrhoea—Melphalan—ovarian cancer	0.000152	0.00115	CcSEcCtD
Clomifene—Diplopia—Epirubicin—ovarian cancer	0.000152	0.00115	CcSEcCtD
Clomifene—Nausea—Chlorambucil—ovarian cancer	0.000151	0.00114	CcSEcCtD
Clomifene—Vision blurred—Paclitaxel—ovarian cancer	0.00015	0.00114	CcSEcCtD
Clomifene—Hot flush—Doxorubicin—ovarian cancer	0.00015	0.00113	CcSEcCtD
Clomifene—Visual impairment—Docetaxel—ovarian cancer	0.00015	0.00113	CcSEcCtD
Clomifene—Dizziness—Topotecan—ovarian cancer	0.00015	0.00113	CcSEcCtD
Clomifene—Increased appetite—Doxorubicin—ovarian cancer	0.000149	0.00113	CcSEcCtD
Clomifene—Affect lability—Epirubicin—ovarian cancer	0.000149	0.00113	CcSEcCtD
Clomifene—Migraine—Epirubicin—ovarian cancer	0.000149	0.00113	CcSEcCtD
Clomifene—Menopausal symptoms—Doxorubicin—ovarian cancer	0.000149	0.00113	CcSEcCtD
Clomifene—Erythema multiforme—Docetaxel—ovarian cancer	0.000147	0.00111	CcSEcCtD
Clomifene—Flushing—Docetaxel—ovarian cancer	0.000144	0.00109	CcSEcCtD
Clomifene—Vomiting—Topotecan—ovarian cancer	0.000144	0.00109	CcSEcCtD
Clomifene—Mood swings—Epirubicin—ovarian cancer	0.000144	0.00109	CcSEcCtD
Clomifene—Vertigo—Paclitaxel—ovarian cancer	0.000143	0.00109	CcSEcCtD
Clomifene—Syncope—Paclitaxel—ovarian cancer	0.000143	0.00108	CcSEcCtD
Clomifene—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000143	0.00108	CcSEcCtD
Clomifene—Rash—Topotecan—ovarian cancer	0.000143	0.00108	CcSEcCtD
Clomifene—Hypersensitivity—Vinorelbine—ovarian cancer	0.000143	0.00108	CcSEcCtD
Clomifene—Dermatitis—Topotecan—ovarian cancer	0.000143	0.00108	CcSEcCtD
Clomifene—Headache—Topotecan—ovarian cancer	0.000142	0.00107	CcSEcCtD
Clomifene—Palpitations—Paclitaxel—ovarian cancer	0.000141	0.00107	CcSEcCtD
Clomifene—Vomiting—Melphalan—ovarian cancer	0.000141	0.00107	CcSEcCtD
Clomifene—Loss of consciousness—Paclitaxel—ovarian cancer	0.00014	0.00106	CcSEcCtD
Clomifene—Diplopia—Doxorubicin—ovarian cancer	0.00014	0.00106	CcSEcCtD
Clomifene—Rash—Melphalan—ovarian cancer	0.00014	0.00106	CcSEcCtD
Clomifene—Dermatitis—Melphalan—ovarian cancer	0.00014	0.00106	CcSEcCtD
Clomifene—Asthenia—Vinorelbine—ovarian cancer	0.000139	0.00105	CcSEcCtD
Clomifene—Arrhythmia—Docetaxel—ovarian cancer	0.000139	0.00105	CcSEcCtD
Clomifene—Convulsion—Paclitaxel—ovarian cancer	0.000138	0.00105	CcSEcCtD
Clomifene—Affect lability—Doxorubicin—ovarian cancer	0.000138	0.00105	CcSEcCtD
Clomifene—Migraine—Doxorubicin—ovarian cancer	0.000138	0.00105	CcSEcCtD
Clomifene—Hypertension—Paclitaxel—ovarian cancer	0.000138	0.00104	CcSEcCtD
Clomifene—Alopecia—Docetaxel—ovarian cancer	0.000137	0.00104	CcSEcCtD
Clomifene—Pruritus—Vinorelbine—ovarian cancer	0.000137	0.00104	CcSEcCtD
Clomifene—Myalgia—Paclitaxel—ovarian cancer	0.000136	0.00103	CcSEcCtD
Clomifene—Chest pain—Paclitaxel—ovarian cancer	0.000136	0.00103	CcSEcCtD
Clomifene—Arthralgia—Paclitaxel—ovarian cancer	0.000136	0.00103	CcSEcCtD
Clomifene—Anxiety—Paclitaxel—ovarian cancer	0.000135	0.00103	CcSEcCtD
Clomifene—Erythema—Docetaxel—ovarian cancer	0.000135	0.00102	CcSEcCtD
Clomifene—Nausea—Topotecan—ovarian cancer	0.000135	0.00102	CcSEcCtD
Clomifene—Mood swings—Doxorubicin—ovarian cancer	0.000133	0.00101	CcSEcCtD
Clomifene—Diarrhoea—Vinorelbine—ovarian cancer	0.000133	0.001	CcSEcCtD
Clomifene—Abdominal distension—Epirubicin—ovarian cancer	0.000132	0.000998	CcSEcCtD
Clomifene—Nausea—Melphalan—ovarian cancer	0.000132	0.000997	CcSEcCtD
Clomifene—Back pain—Docetaxel—ovarian cancer	0.000131	0.000991	CcSEcCtD
Clomifene—Oedema—Paclitaxel—ovarian cancer	0.00013	0.000986	CcSEcCtD
Clomifene—Pancreatitis—Epirubicin—ovarian cancer	0.000128	0.000972	CcSEcCtD
Clomifene—Shock—Paclitaxel—ovarian cancer	0.000128	0.000971	CcSEcCtD
Clomifene—Dizziness—Vinorelbine—ovarian cancer	0.000128	0.00097	CcSEcCtD
Clomifene—Tachycardia—Paclitaxel—ovarian cancer	0.000127	0.000963	CcSEcCtD
Clomifene—Vomiting—Vinorelbine—ovarian cancer	0.000123	0.000933	CcSEcCtD
Clomifene—Rash—Vinorelbine—ovarian cancer	0.000122	0.000925	CcSEcCtD
Clomifene—Dermatitis—Vinorelbine—ovarian cancer	0.000122	0.000924	CcSEcCtD
Clomifene—Abdominal distension—Doxorubicin—ovarian cancer	0.000122	0.000924	CcSEcCtD
Clomifene—Headache—Vinorelbine—ovarian cancer	0.000121	0.000919	CcSEcCtD
Clomifene—Syncope—Docetaxel—ovarian cancer	0.000121	0.000919	CcSEcCtD
Clomifene—Pollakiuria—Epirubicin—ovarian cancer	0.000121	0.000916	CcSEcCtD
Clomifene—Palpitations—Docetaxel—ovarian cancer	0.00012	0.000905	CcSEcCtD
Clomifene—Weight increased—Epirubicin—ovarian cancer	0.000119	0.000903	CcSEcCtD
Clomifene—Loss of consciousness—Docetaxel—ovarian cancer	0.000119	0.0009	CcSEcCtD
Clomifene—Pancreatitis—Doxorubicin—ovarian cancer	0.000119	0.0009	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000119	0.000899	CcSEcCtD
Clomifene—Insomnia—Paclitaxel—ovarian cancer	0.000118	0.000892	CcSEcCtD
Clomifene—Convulsion—Docetaxel—ovarian cancer	0.000117	0.000888	CcSEcCtD
Clomifene—Paraesthesia—Paclitaxel—ovarian cancer	0.000117	0.000886	CcSEcCtD
Clomifene—Tamoxifen—ABCB1—ovarian cancer	0.000117	0.0445	CrCbGaD
Clomifene—Hypertension—Docetaxel—ovarian cancer	0.000117	0.000885	CcSEcCtD
Clomifene—ABCB1—lymph node—ovarian cancer	0.000116	0.00108	CbGeAlD
Clomifene—Dyspnoea—Paclitaxel—ovarian cancer	0.000116	0.000879	CcSEcCtD
Clomifene—Chest pain—Docetaxel—ovarian cancer	0.000115	0.000872	CcSEcCtD
Clomifene—Myalgia—Docetaxel—ovarian cancer	0.000115	0.000872	CcSEcCtD
Clomifene—Arthralgia—Docetaxel—ovarian cancer	0.000115	0.000872	CcSEcCtD
Clomifene—Nausea—Vinorelbine—ovarian cancer	0.000115	0.000871	CcSEcCtD
Clomifene—Renal failure—Epirubicin—ovarian cancer	0.000115	0.000869	CcSEcCtD
Clomifene—Jaundice—Epirubicin—ovarian cancer	0.000114	0.000862	CcSEcCtD
Clomifene—Fatigue—Paclitaxel—ovarian cancer	0.000112	0.000851	CcSEcCtD
Clomifene—Pollakiuria—Doxorubicin—ovarian cancer	0.000112	0.000848	CcSEcCtD
Clomifene—Pain—Paclitaxel—ovarian cancer	0.000111	0.000844	CcSEcCtD
Clomifene—Constipation—Paclitaxel—ovarian cancer	0.000111	0.000844	CcSEcCtD
Clomifene—Oedema—Docetaxel—ovarian cancer	0.00011	0.000836	CcSEcCtD
Clomifene—Weight increased—Doxorubicin—ovarian cancer	0.00011	0.000835	CcSEcCtD
Clomifene—Shock—Docetaxel—ovarian cancer	0.000109	0.000823	CcSEcCtD
Clomifene—Tachycardia—Docetaxel—ovarian cancer	0.000108	0.000816	CcSEcCtD
Clomifene—Renal failure—Doxorubicin—ovarian cancer	0.000106	0.000804	CcSEcCtD
Clomifene—Jaundice—Doxorubicin—ovarian cancer	0.000105	0.000798	CcSEcCtD
Clomifene—Hepatitis—Epirubicin—ovarian cancer	0.000105	0.000794	CcSEcCtD
Clomifene—Urticaria—Paclitaxel—ovarian cancer	0.000104	0.000784	CcSEcCtD
Clomifene—Body temperature increased—Paclitaxel—ovarian cancer	0.000103	0.00078	CcSEcCtD
Clomifene—Visual impairment—Epirubicin—ovarian cancer	0.000101	0.000765	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000101	0.000762	CcSEcCtD
Clomifene—Insomnia—Docetaxel—ovarian cancer	9.99e-05	0.000756	CcSEcCtD
Clomifene—Paraesthesia—Docetaxel—ovarian cancer	9.92e-05	0.000751	CcSEcCtD
Clomifene—Erythema multiforme—Epirubicin—ovarian cancer	9.91e-05	0.000751	CcSEcCtD
Clomifene—Dyspnoea—Docetaxel—ovarian cancer	9.85e-05	0.000745	CcSEcCtD
Clomifene—Tinnitus—Epirubicin—ovarian cancer	9.78e-05	0.00074	CcSEcCtD
Clomifene—Flushing—Epirubicin—ovarian cancer	9.73e-05	0.000737	CcSEcCtD
Clomifene—Hepatitis—Doxorubicin—ovarian cancer	9.7e-05	0.000735	CcSEcCtD
Clomifene—Hypersensitivity—Paclitaxel—ovarian cancer	9.6e-05	0.000727	CcSEcCtD
Clomifene—Fatigue—Docetaxel—ovarian cancer	9.52e-05	0.000721	CcSEcCtD
Clomifene—Constipation—Docetaxel—ovarian cancer	9.44e-05	0.000715	CcSEcCtD
Clomifene—Pain—Docetaxel—ovarian cancer	9.44e-05	0.000715	CcSEcCtD
Clomifene—Arrhythmia—Epirubicin—ovarian cancer	9.37e-05	0.000709	CcSEcCtD
Clomifene—Visual impairment—Doxorubicin—ovarian cancer	9.35e-05	0.000708	CcSEcCtD
Clomifene—Asthenia—Paclitaxel—ovarian cancer	9.35e-05	0.000708	CcSEcCtD
Clomifene—Alopecia—Epirubicin—ovarian cancer	9.26e-05	0.000701	CcSEcCtD
Clomifene—Pruritus—Paclitaxel—ovarian cancer	9.22e-05	0.000698	CcSEcCtD
Clomifene—Erythema multiforme—Doxorubicin—ovarian cancer	9.17e-05	0.000694	CcSEcCtD
Clomifene—Erythema—Epirubicin—ovarian cancer	9.13e-05	0.000691	CcSEcCtD
Clomifene—Tinnitus—Doxorubicin—ovarian cancer	9.05e-05	0.000685	CcSEcCtD
Clomifene—Flushing—Doxorubicin—ovarian cancer	9e-05	0.000682	CcSEcCtD
Clomifene—Flatulence—Epirubicin—ovarian cancer	8.99e-05	0.000681	CcSEcCtD
Clomifene—Tension—Epirubicin—ovarian cancer	8.96e-05	0.000678	CcSEcCtD
Clomifene—Diarrhoea—Paclitaxel—ovarian cancer	8.91e-05	0.000675	CcSEcCtD
Clomifene—Nervousness—Epirubicin—ovarian cancer	8.86e-05	0.000671	CcSEcCtD
Clomifene—Back pain—Epirubicin—ovarian cancer	8.83e-05	0.000668	CcSEcCtD
Clomifene—Body temperature increased—Docetaxel—ovarian cancer	8.73e-05	0.000661	CcSEcCtD
Clomifene—Arrhythmia—Doxorubicin—ovarian cancer	8.67e-05	0.000656	CcSEcCtD
Clomifene—Dizziness—Paclitaxel—ovarian cancer	8.62e-05	0.000652	CcSEcCtD
Clomifene—Vision blurred—Epirubicin—ovarian cancer	8.6e-05	0.000651	CcSEcCtD
Clomifene—Alopecia—Doxorubicin—ovarian cancer	8.57e-05	0.000649	CcSEcCtD
Clomifene—Erythema—Doxorubicin—ovarian cancer	8.45e-05	0.000639	CcSEcCtD
Clomifene—Flatulence—Doxorubicin—ovarian cancer	8.32e-05	0.00063	CcSEcCtD
Clomifene—Tension—Doxorubicin—ovarian cancer	8.29e-05	0.000627	CcSEcCtD
Clomifene—Vomiting—Paclitaxel—ovarian cancer	8.28e-05	0.000627	CcSEcCtD
Clomifene—Rash—Paclitaxel—ovarian cancer	8.22e-05	0.000622	CcSEcCtD
Clomifene—Dermatitis—Paclitaxel—ovarian cancer	8.21e-05	0.000621	CcSEcCtD
Clomifene—Nervousness—Doxorubicin—ovarian cancer	8.2e-05	0.000621	CcSEcCtD
Clomifene—Vertigo—Epirubicin—ovarian cancer	8.2e-05	0.000621	CcSEcCtD
Clomifene—Syncope—Epirubicin—ovarian cancer	8.18e-05	0.00062	CcSEcCtD
Clomifene—Back pain—Doxorubicin—ovarian cancer	8.17e-05	0.000618	CcSEcCtD
Clomifene—Headache—Paclitaxel—ovarian cancer	8.16e-05	0.000618	CcSEcCtD
Clomifene—Hypersensitivity—Docetaxel—ovarian cancer	8.14e-05	0.000616	CcSEcCtD
Clomifene—Palpitations—Epirubicin—ovarian cancer	8.07e-05	0.000611	CcSEcCtD
Clomifene—Loss of consciousness—Epirubicin—ovarian cancer	8.02e-05	0.000607	CcSEcCtD
Clomifene—Vision blurred—Doxorubicin—ovarian cancer	7.96e-05	0.000603	CcSEcCtD
Clomifene—Asthenia—Docetaxel—ovarian cancer	7.92e-05	0.0006	CcSEcCtD
Clomifene—Convulsion—Epirubicin—ovarian cancer	7.91e-05	0.000599	CcSEcCtD
Clomifene—Hypertension—Epirubicin—ovarian cancer	7.88e-05	0.000597	CcSEcCtD
Clomifene—Pruritus—Docetaxel—ovarian cancer	7.81e-05	0.000592	CcSEcCtD
Clomifene—Myalgia—Epirubicin—ovarian cancer	7.77e-05	0.000588	CcSEcCtD
Clomifene—Chest pain—Epirubicin—ovarian cancer	7.77e-05	0.000588	CcSEcCtD
Clomifene—Arthralgia—Epirubicin—ovarian cancer	7.77e-05	0.000588	CcSEcCtD
Clomifene—Anxiety—Epirubicin—ovarian cancer	7.74e-05	0.000586	CcSEcCtD
Clomifene—Nausea—Paclitaxel—ovarian cancer	7.74e-05	0.000586	CcSEcCtD
Clomifene—Vertigo—Doxorubicin—ovarian cancer	7.59e-05	0.000574	CcSEcCtD
Clomifene—Syncope—Doxorubicin—ovarian cancer	7.57e-05	0.000573	CcSEcCtD
Clomifene—Diarrhoea—Docetaxel—ovarian cancer	7.56e-05	0.000572	CcSEcCtD
Clomifene—Palpitations—Doxorubicin—ovarian cancer	7.46e-05	0.000565	CcSEcCtD
Clomifene—Oedema—Epirubicin—ovarian cancer	7.45e-05	0.000564	CcSEcCtD
Clomifene—Loss of consciousness—Doxorubicin—ovarian cancer	7.42e-05	0.000562	CcSEcCtD
Clomifene—Shock—Epirubicin—ovarian cancer	7.33e-05	0.000555	CcSEcCtD
Clomifene—Convulsion—Doxorubicin—ovarian cancer	7.32e-05	0.000554	CcSEcCtD
Clomifene—Dizziness—Docetaxel—ovarian cancer	7.3e-05	0.000553	CcSEcCtD
Clomifene—Hypertension—Doxorubicin—ovarian cancer	7.29e-05	0.000552	CcSEcCtD
Clomifene—Tachycardia—Epirubicin—ovarian cancer	7.27e-05	0.00055	CcSEcCtD
Clomifene—Myalgia—Doxorubicin—ovarian cancer	7.19e-05	0.000544	CcSEcCtD
Clomifene—Arthralgia—Doxorubicin—ovarian cancer	7.19e-05	0.000544	CcSEcCtD
Clomifene—Chest pain—Doxorubicin—ovarian cancer	7.19e-05	0.000544	CcSEcCtD
Clomifene—Anxiety—Doxorubicin—ovarian cancer	7.16e-05	0.000542	CcSEcCtD
Clomifene—Vomiting—Docetaxel—ovarian cancer	7.02e-05	0.000532	CcSEcCtD
Clomifene—Rash—Docetaxel—ovarian cancer	6.96e-05	0.000527	CcSEcCtD
Clomifene—Dermatitis—Docetaxel—ovarian cancer	6.96e-05	0.000527	CcSEcCtD
Clomifene—Headache—Docetaxel—ovarian cancer	6.92e-05	0.000524	CcSEcCtD
Clomifene—Oedema—Doxorubicin—ovarian cancer	6.89e-05	0.000522	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Epirubicin—ovarian cancer	6.79e-05	0.000514	CcSEcCtD
Clomifene—Shock—Doxorubicin—ovarian cancer	6.78e-05	0.000513	CcSEcCtD
Clomifene—Insomnia—Epirubicin—ovarian cancer	6.74e-05	0.00051	CcSEcCtD
Clomifene—Tachycardia—Doxorubicin—ovarian cancer	6.73e-05	0.000509	CcSEcCtD
Clomifene—Paraesthesia—Epirubicin—ovarian cancer	6.69e-05	0.000506	CcSEcCtD
Clomifene—Dyspnoea—Epirubicin—ovarian cancer	6.64e-05	0.000503	CcSEcCtD
Clomifene—Nausea—Docetaxel—ovarian cancer	6.56e-05	0.000497	CcSEcCtD
Clomifene—Fatigue—Epirubicin—ovarian cancer	6.42e-05	0.000486	CcSEcCtD
Clomifene—Pain—Epirubicin—ovarian cancer	6.37e-05	0.000482	CcSEcCtD
Clomifene—Constipation—Epirubicin—ovarian cancer	6.37e-05	0.000482	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	6.28e-05	0.000475	CcSEcCtD
Clomifene—Insomnia—Doxorubicin—ovarian cancer	6.23e-05	0.000472	CcSEcCtD
Clomifene—Paraesthesia—Doxorubicin—ovarian cancer	6.19e-05	0.000469	CcSEcCtD
Clomifene—Dyspnoea—Doxorubicin—ovarian cancer	6.14e-05	0.000465	CcSEcCtD
Clomifene—Fatigue—Doxorubicin—ovarian cancer	5.94e-05	0.00045	CcSEcCtD
Clomifene—Urticaria—Epirubicin—ovarian cancer	5.92e-05	0.000448	CcSEcCtD
Clomifene—Pain—Doxorubicin—ovarian cancer	5.89e-05	0.000446	CcSEcCtD
Clomifene—Constipation—Doxorubicin—ovarian cancer	5.89e-05	0.000446	CcSEcCtD
Clomifene—Body temperature increased—Epirubicin—ovarian cancer	5.89e-05	0.000446	CcSEcCtD
Clomifene—Hypersensitivity—Epirubicin—ovarian cancer	5.49e-05	0.000416	CcSEcCtD
Clomifene—Urticaria—Doxorubicin—ovarian cancer	5.48e-05	0.000415	CcSEcCtD
Clomifene—Body temperature increased—Doxorubicin—ovarian cancer	5.45e-05	0.000413	CcSEcCtD
Clomifene—Asthenia—Epirubicin—ovarian cancer	5.34e-05	0.000405	CcSEcCtD
Clomifene—Pruritus—Epirubicin—ovarian cancer	5.27e-05	0.000399	CcSEcCtD
Clomifene—Diarrhoea—Epirubicin—ovarian cancer	5.1e-05	0.000386	CcSEcCtD
Clomifene—Hypersensitivity—Doxorubicin—ovarian cancer	5.08e-05	0.000384	CcSEcCtD
Clomifene—Asthenia—Doxorubicin—ovarian cancer	4.95e-05	0.000374	CcSEcCtD
Clomifene—Dizziness—Epirubicin—ovarian cancer	4.93e-05	0.000373	CcSEcCtD
Clomifene—Pruritus—Doxorubicin—ovarian cancer	4.88e-05	0.000369	CcSEcCtD
Clomifene—Vomiting—Epirubicin—ovarian cancer	4.74e-05	0.000359	CcSEcCtD
Clomifene—Diarrhoea—Doxorubicin—ovarian cancer	4.72e-05	0.000357	CcSEcCtD
Clomifene—Rash—Epirubicin—ovarian cancer	4.7e-05	0.000356	CcSEcCtD
Clomifene—Dermatitis—Epirubicin—ovarian cancer	4.69e-05	0.000355	CcSEcCtD
Clomifene—Headache—Epirubicin—ovarian cancer	4.67e-05	0.000353	CcSEcCtD
Clomifene—Dizziness—Doxorubicin—ovarian cancer	4.56e-05	0.000345	CcSEcCtD
Clomifene—Nausea—Epirubicin—ovarian cancer	4.42e-05	0.000335	CcSEcCtD
Clomifene—Vomiting—Doxorubicin—ovarian cancer	4.38e-05	0.000332	CcSEcCtD
Clomifene—Rash—Doxorubicin—ovarian cancer	4.35e-05	0.000329	CcSEcCtD
Clomifene—Dermatitis—Doxorubicin—ovarian cancer	4.34e-05	0.000329	CcSEcCtD
Clomifene—Headache—Doxorubicin—ovarian cancer	4.32e-05	0.000327	CcSEcCtD
Clomifene—Nausea—Doxorubicin—ovarian cancer	4.09e-05	0.00031	CcSEcCtD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	2.65e-05	0.000495	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.63e-05	0.000491	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—PIK3CA—ovarian cancer	2.61e-05	0.000487	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.6e-05	0.000486	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—DOK1—ovarian cancer	2.6e-05	0.000486	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PPP1CC—ovarian cancer	2.6e-05	0.000486	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—BRIP1—ovarian cancer	2.6e-05	0.000486	CbGpPWpGaD
Clomifene—EBP—Metabolism—PIK3CB—ovarian cancer	2.58e-05	0.000483	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—SLC2A1—ovarian cancer	2.56e-05	0.000479	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.56e-05	0.000478	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	2.54e-05	0.000474	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—YAP1—ovarian cancer	2.52e-05	0.000471	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.51e-05	0.000469	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.5e-05	0.000468	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.5e-05	0.000468	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.46e-05	0.00046	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CYP1B1—ovarian cancer	2.46e-05	0.000459	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PPP1CC—ovarian cancer	2.45e-05	0.000457	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—HRAS—ovarian cancer	2.41e-05	0.000451	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	2.39e-05	0.000447	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.38e-05	0.000445	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.38e-05	0.000444	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.36e-05	0.000442	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYTB—ovarian cancer	2.35e-05	0.000439	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—IL6—ovarian cancer	2.31e-05	0.000431	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—HRAS—ovarian cancer	2.3e-05	0.00043	CbGpPWpGaD
Clomifene—EBP—Metabolism—PTEN—ovarian cancer	2.23e-05	0.000417	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYTB—ovarian cancer	2.22e-05	0.000414	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—PGR—ovarian cancer	2.2e-05	0.000412	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.2e-05	0.00041	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—NME2—ovarian cancer	2.19e-05	0.00041	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—YAP1—ovarian cancer	2.19e-05	0.000409	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PPP2R1A—ovarian cancer	2.18e-05	0.000407	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.17e-05	0.000406	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.17e-05	0.000405	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.17e-05	0.000405	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.17e-05	0.000405	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	2.14e-05	0.0004	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—AKT1—ovarian cancer	2.13e-05	0.000398	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.1e-05	0.000393	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—BRIP1—ovarian cancer	2.06e-05	0.000384	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PPP1CC—ovarian cancer	2.06e-05	0.000384	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—PARP1—ovarian cancer	2.05e-05	0.000383	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—ABCB1—ovarian cancer	2.02e-05	0.000378	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—TYMS—ovarian cancer	1.99e-05	0.000371	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—BRIP1—ovarian cancer	1.94e-05	0.000362	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PPP1CC—ovarian cancer	1.94e-05	0.000362	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.91e-05	0.000357	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.91e-05	0.000356	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.86e-05	0.000348	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HDAC6—ovarian cancer	1.85e-05	0.000346	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—FASN—ovarian cancer	1.79e-05	0.000334	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.78e-05	0.000332	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.77e-05	0.000331	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYTB—ovarian cancer	1.77e-05	0.000331	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.77e-05	0.000331	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—SLC5A5—ovarian cancer	1.76e-05	0.000328	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—YAP1—ovarian cancer	1.74e-05	0.000326	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.73e-05	0.000324	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.72e-05	0.000321	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—SLC2A1—ovarian cancer	1.7e-05	0.000317	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—NME2—ovarian cancer	1.69e-05	0.000316	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.69e-05	0.000315	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.67e-05	0.000312	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.66e-05	0.00031	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—PPP2R1A—ovarian cancer	1.66e-05	0.00031	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—YAP1—ovarian cancer	1.64e-05	0.000307	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.63e-05	0.000304	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CYP1B1—ovarian cancer	1.63e-05	0.000304	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—XIAP—ovarian cancer	1.61e-05	0.0003	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CAV1—ovarian cancer	1.6e-05	0.000299	CbGpPWpGaD
Clomifene—EBP—Metabolism—PIK3CA—ovarian cancer	1.57e-05	0.000294	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SMARCA4—ovarian cancer	1.57e-05	0.000293	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—BRIP1—ovarian cancer	1.55e-05	0.000289	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.55e-05	0.000289	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.53e-05	0.000286	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EREG—ovarian cancer	1.53e-05	0.000286	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.52e-05	0.000283	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.47e-05	0.000275	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CG—ovarian cancer	1.46e-05	0.000272	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	1.44e-05	0.00027	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.44e-05	0.000268	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PGR—ovarian cancer	1.43e-05	0.000268	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—FASN—ovarian cancer	1.42e-05	0.000266	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYTB—ovarian cancer	1.41e-05	0.000264	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.41e-05	0.000264	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—SLC5A5—ovarian cancer	1.4e-05	0.000261	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.39e-05	0.00026	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.38e-05	0.000258	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—YAP1—ovarian cancer	1.38e-05	0.000258	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.35e-05	0.000253	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—SLC2A1—ovarian cancer	1.35e-05	0.000252	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ABCB1—ovarian cancer	1.34e-05	0.00025	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PARP1—ovarian cancer	1.33e-05	0.000249	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.32e-05	0.000247	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.32e-05	0.000247	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—TYMS—ovarian cancer	1.32e-05	0.000246	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—YAP1—ovarian cancer	1.3e-05	0.000243	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYP1B1—ovarian cancer	1.29e-05	0.000242	CbGpPWpGaD
Clomifene—EBP—Metabolism—AKT1—ovarian cancer	1.29e-05	0.00024	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.29e-05	0.00024	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CD—ovarian cancer	1.28e-05	0.000239	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—MYC—ovarian cancer	1.27e-05	0.000237	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.25e-05	0.000234	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.24e-05	0.000231	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.24e-05	0.000231	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.15e-05	0.000215	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	1.15e-05	0.000215	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.13e-05	0.000211	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—FASN—ovarian cancer	1.12e-05	0.00021	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CB—ovarian cancer	1.12e-05	0.000209	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.11e-05	0.000208	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.11e-05	0.000207	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYTB—ovarian cancer	1.09e-05	0.000204	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PPP2R1A—ovarian cancer	1.08e-05	0.000202	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.07e-05	0.000199	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ABCB1—ovarian cancer	1.07e-05	0.000199	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CAV1—ovarian cancer	1.06e-05	0.000198	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—FASN—ovarian cancer	1.06e-05	0.000198	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—TYMS—ovarian cancer	1.05e-05	0.000196	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—SLC5A5—ovarian cancer	1.04e-05	0.000195	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—YAP1—ovarian cancer	1.04e-05	0.000194	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP1B1—ovarian cancer	1.02e-05	0.000191	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.01e-05	0.000189	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—SLC2A1—ovarian cancer	1.01e-05	0.000188	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.85e-06	0.000184	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CG—ovarian cancer	9.66e-06	0.00018	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PTEN—ovarian cancer	9.65e-06	0.00018	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP1B1—ovarian cancer	9.65e-06	0.00018	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PPP1CC—ovarian cancer	9.53e-06	0.000178	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—BRIP1—ovarian cancer	9.53e-06	0.000178	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	9.39e-06	0.000175	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	9.08e-06	0.00017	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9e-06	0.000168	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TERT—ovarian cancer	8.58e-06	0.00016	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	8.56e-06	0.00016	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.52e-06	0.000159	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CD—ovarian cancer	8.49e-06	0.000159	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—FASN—ovarian cancer	8.46e-06	0.000158	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CAV1—ovarian cancer	8.44e-06	0.000158	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ABCB1—ovarian cancer	8.43e-06	0.000157	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—SLC5A5—ovarian cancer	8.32e-06	0.000156	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—YAP1—ovarian cancer	8.29e-06	0.000155	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—TYMS—ovarian cancer	8.28e-06	0.000155	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.2e-06	0.000153	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—SLC2A1—ovarian cancer	8.04e-06	0.00015	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ABCB1—ovarian cancer	7.95e-06	0.000148	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CAV1—ovarian cancer	7.94e-06	0.000148	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—TYMS—ovarian cancer	7.8e-06	0.000146	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP1B1—ovarian cancer	7.71e-06	0.000144	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CG—ovarian cancer	7.69e-06	0.000144	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IL6ST—ovarian cancer	7.52e-06	0.000141	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CB—ovarian cancer	7.4e-06	0.000138	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—APC—ovarian cancer	7.23e-06	0.000135	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	7.23e-06	0.000135	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.21e-06	0.000135	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PPP2R1A—ovarian cancer	6.83e-06	0.000128	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CA—ovarian cancer	6.81e-06	0.000127	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CD—ovarian cancer	6.76e-06	0.000126	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—FASN—ovarian cancer	6.75e-06	0.000126	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CAV1—ovarian cancer	6.67e-06	0.000125	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—SLC5A5—ovarian cancer	6.64e-06	0.000124	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—SLC2A1—ovarian cancer	6.42e-06	0.00012	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—YAP1—ovarian cancer	6.39e-06	0.000119	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PTEN—ovarian cancer	6.39e-06	0.000119	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	6.36e-06	0.000119	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—MAPK3—ovarian cancer	6.29e-06	0.000118	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CAV1—ovarian cancer	6.29e-06	0.000117	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.28e-06	0.000117	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—TYMS—ovarian cancer	6.23e-06	0.000116	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP1B1—ovarian cancer	6.15e-06	0.000115	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—MYC—ovarian cancer	6.12e-06	0.000114	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CG—ovarian cancer	6.07e-06	0.000114	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.01e-06	0.000112	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CB—ovarian cancer	5.89e-06	0.00011	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CG—ovarian cancer	5.73e-06	0.000107	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ERBB2—ovarian cancer	5.61e-06	0.000105	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—AKT1—ovarian cancer	5.56e-06	0.000104	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MTOR—ovarian cancer	5.54e-06	0.000104	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	5.54e-06	0.000104	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	5.46e-06	0.000102	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.43e-06	0.000101	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CD—ovarian cancer	5.34e-06	9.98e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CXCL8—ovarian cancer	5.32e-06	9.95e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—FASN—ovarian cancer	5.21e-06	9.74e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	5.2e-06	9.71e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.13e-06	9.58e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CASP3—ovarian cancer	5.1e-06	9.52e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PTEN—ovarian cancer	5.09e-06	9.51e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IL2—ovarian cancer	5.09e-06	9.51e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ABCB1—ovarian cancer	5.07e-06	9.47e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CD—ovarian cancer	5.03e-06	9.41e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CAV1—ovarian cancer	5.02e-06	9.38e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—TYMS—ovarian cancer	4.98e-06	9.3e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CCND1—ovarian cancer	4.96e-06	9.27e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.95e-06	9.25e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	4.91e-06	9.18e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MMP9—ovarian cancer	4.82e-06	9e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PTEN—ovarian cancer	4.79e-06	8.94e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.75e-06	8.87e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CB—ovarian cancer	4.65e-06	8.7e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.57e-06	8.55e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CA—ovarian cancer	4.51e-06	8.43e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CB—ovarian cancer	4.39e-06	8.2e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—VEGFA—ovarian cancer	4.32e-06	8.08e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—STAT3—ovarian cancer	4.28e-06	8e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NRAS—ovarian cancer	4.27e-06	7.98e-05	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—AKT1—ovarian cancer	4.24e-06	7.93e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.21e-06	7.87e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MAPK3—ovarian cancer	4.09e-06	7.64e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PTEN—ovarian cancer	4.02e-06	7.52e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.02e-06	7.51e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CAV1—ovarian cancer	4.01e-06	7.49e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MYC—ovarian cancer	3.98e-06	7.43e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.91e-06	7.31e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MAPK1—ovarian cancer	3.89e-06	7.27e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EGFR—ovarian cancer	3.89e-06	7.27e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—TYMS—ovarian cancer	3.84e-06	7.17e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.83e-06	7.16e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PTEN—ovarian cancer	3.79e-06	7.09e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—AKT1—ovarian cancer	3.69e-06	6.89e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KRAS—ovarian cancer	3.68e-06	6.87e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CG—ovarian cancer	3.65e-06	6.82e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CA—ovarian cancer	3.59e-06	6.71e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.51e-06	6.55e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	3.38e-06	6.31e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—ovarian cancer	3.27e-06	6.1e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CD—ovarian cancer	3.21e-06	6e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HRAS—ovarian cancer	3.12e-06	5.84e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CAV1—ovarian cancer	3.09e-06	5.78e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PTEN—ovarian cancer	3.03e-06	5.66e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IL6—ovarian cancer	2.99e-06	5.59e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—AKT1—ovarian cancer	2.93e-06	5.48e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CA—ovarian cancer	2.84e-06	5.3e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.82e-06	5.27e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.8e-06	5.23e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AKT1—ovarian cancer	2.76e-06	5.15e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CA—ovarian cancer	2.68e-06	5e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.48e-06	4.63e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PTEN—ovarian cancer	2.42e-06	4.52e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—AKT1—ovarian cancer	2.32e-06	4.33e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—AKT1—ovarian cancer	2.19e-06	4.08e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.16e-06	4.04e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.14e-06	3.99e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PTEN—ovarian cancer	1.87e-06	3.49e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—AKT1—ovarian cancer	1.75e-06	3.26e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.71e-06	3.19e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—AKT1—ovarian cancer	1.39e-06	2.6e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.32e-06	2.46e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—AKT1—ovarian cancer	1.08e-06	2.01e-05	CbGpPWpGaD
